The case for limiting acetaminophen-related deaths: Smaller doses and unbundling the opioid-acetaminophen compounds

Clinical Pharmacology and Therapeutics

Volumn 88, Issue 3, 2010, Pages 289-292

  Lee, W M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; BENZODIAZEPINE; COCAINE; DIPHENHYDRAMINE; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL;

DRUG INTOXICATION; DRUG MISUSE; DRUG OVERDOSE; DRUG PACKAGING; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GENETIC SUSCEPTIBILITY; HUMAN; LIVER FAILURE; LIVER TOXICITY; NONHUMAN; PAIN; PRESCRIPTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUICIDE ATTEMPT; TOXICITY TESTING; URINALYSIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG-INDUCED LIVER INJURY; HUMANS; LIVER FAILURE; OVERDOSE;

EID: 77955907215     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2010.164     Document Type: Review

References (11)

1. Schiødt, F.V. et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transplant Surg. 5, 29-34 (1999).
2. Ostapowicz, G.A. et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann. Intern. Med. 137, 945-954 (2002).
3. Lee, W.M. Acetaminophen hepatotoxicity: changing perceptions of a social/medical issue. Hepatology 46, 966-970 (2007).
4. US Food and Drug Administration. FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers to Help Consumers Use Products Safely (28 April 2009).
5. Larson, A.M. et al. And the ALFSG. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42, 1367-1372 (2005).
6. Shayiq, R.M. et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 29, 451-463 (1999).
7. Whitcomb, D.C. & Block, G.D. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 272, 1845-1850 (1994).
8. US Food and Drug Administration, Center for Drug Evaluation and Research. Joint Meeting of the Drug Safety and Risk Management Advisory Committee, Nonprescription Drugs Advisory Committee, and the Anesthetic and Life Support Drugs Advisory Committee. Questions to the Committee (29-30 June 2009).
9. Watkins, P.B. et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 296, 87-93 (2006).
10. Harrill, A.H. et al. Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury. Genome Res. 19, 1507-1515 (2009).
11. Drug Topics. Top 200 Generic Drugs by Units in 2006 (2006).